Introduction. Rosai-Dorfman disease is a rare non-Langerhans cell histiocytosis that may closely mimic malignant disease, particularly in extranodal soft tissue. Its progression during active systemic therapy has been only rarely reported.
Case presentation. We report a case of localized extranodal inguinofemoral Rosai-Dorfman disease progressing despite six cycles of cladribine. A 52-year-old man presented with progressive enlargement of a right inguinofemoral mass despite six cycles of cladribine. The lesion subsequently developed tissue necrosis, hemorrhage, and secondary infection. The histopathological diagnosis had been established before initiation of systemic therapy. Because of continued disease progression, complete surgical excision was performed under spinal anesthesia, without preoperative cross-sectional imaging because of local resource limitations. The postoperative course was uneventful, and no evidence of local recurrence or disease progression was observed at 3-month follow-up.
Conclusions. Localized extranodal Rosai-Dorfman disease may continue to progress despite appropriately administered systemic therapy, ultimately requiring surgical management. In our case, salvage surgical excision achieved effective short-term local disease control after cladribine failure. Persistent progression during active systemic therapy should prompt consideration of timely surgical reassessment, particularly in resource-limited settings.
Keywords: histiocytosis, emperipolesis, sarcoma, necrosis, resource-limited settings.
Address for correspondence:
Nora OSMËNAJ
Faculty of Medicine, University of Medicine of Tirana, Albania
Address: Rruga e Dibrës Street, Tirana, Albania
E-mail: [nor.osmenaj@gmail.com](mailto:nor.osmenaj@gmail.com); Phone +355 69 669 5812